Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Lee Marvin's stunning estate in Tucson is back on the market after an extensive renovation,…
Lisandro Martinez criticised Manchester United’s hierarchy after their 2-0 Champions League defeat to Atletico Madrid,…
South Africa faced a significant defeat against Australia by 214 runs in the first Test…